RESEARCH FRONTIERS INC Q2 FY2026 earnings call

• Supply Chain Context
  • The core challenge faced over the past nine months is a temporary supply chain disruption stemming from the financial restructuring of principal licensee and SPD film manufacturer Gauzy, not a failure of SPD technology, product market fit, or customer demand.
  • No core company assets were lost: intellectual property, automotive qualifications, development pipelines, customer interest, and existing major programs all remain intact.
  • Strategic Activity During Restructuring
  • A new license agreement was signed with Klein, a division of NYSE-listed Polaris (a global leader in premium motorcycle equipment), to develop SPD applications for helmet visors and sports goggles, representing independent validation of SPD technology's long-term value.
  • Development of black SPD technology continued to advance, with production-ready samples demonstrating strong performance.
  • The retrofit SPD product for the architectural market (led by LTI) continued progressing and is ready to launch once film production returns to normal; LTI's CEO also personally participated in a recent friends-and-family financing, demonstrating confidence in the product.
  • Two new major aircraft OEM programs were won during the restructuring period, and existing automotive programs with Mercedes, Ferrari, Cadillac, and McLaren all remain intact.
  • Management maintained strict expense control to preserve financial flexibility for future growth.
  • Manufacturing Supply Chain Planning
  • Research Frontiers has prepped four contingency plans to restore full SPD film production capacity:
    1. Plan A (most likely): Gauzy completes restructuring and resumes full-scale production of SPD emulsion and film (least supply chain disruption)
    2. Plan B: Gauzy continues producing SPD emulsion, with a third party coating the emulsion into finished film
    3. Plan C: A new qualified manufacturer produces both emulsion and finished film under license
    4. Plan D: Research Frontiers directly participates in acquiring Gauzy SPD manufacturing assets if determined to be in shareholder best interest
  • Corporate Matters
  • A conservative accounting reserve was taken for outstanding receivables due to uncertainty around collection timing from court-supervised restructuring, but management maintains full confidence that all amounts will ultimately be collected.
  • Management is working to regain NASDAQ listing compliance (for the $1 minimum share price requirement) through improved operational and market performance, and prefers this approach over a reverse stock split.
  • A poison pill and other shark repellent provisions are in place to ensure shareholders receive fair value in any potential acquisition offer.

No detailed segment-level financial results (absolute revenue figures or revenue contribution percentages) were provided in this call. Lower royalty revenue overall was acknowledged to result from production disruptions at the company's principal SPD film supplier, Gauzy, but no formal breakdown of performance by product or market segment (automotive, aerospace, architectural, consumer) was shared.

• Management expects Gauzy's court-supervised financial restructuring to be concluded as soon as September 2026, with full production of SPD emulsion and film restarting before the end of 2026.
  • Management expects that after exiting restructuring, Gauzy will emerge as a leaner, better capitalized, and more focused company that can support growing demand for SPD across all end markets.
  • Pent-up customer demand from the supply disruption will be filled shortly after production restarts, with existing delayed programs resuming immediately.
  • Management retains full confidence in the long-term growth opportunity for SPD smart glass across automotive, aerospace, architectural, and new consumer end markets.

• The timing of receivable collection from Gauzy is dependent on court-supervised restructuring proceedings outside of Research Frontiers' control, creating uncertainty for near-term cash flow.
  • Adding a new SPD film manufacturer requires years of development, capital investment, and quality validation to meet automotive OEM requirements, which would delay near-term production growth if a switch from Gauzy becomes necessary.
  • The company has until the end of November 2026 to regain NASDAQ compliance for the $1 minimum share price, and there is no guarantee that improved operational performance will achieve this requirement.
  • Uncertainty remains around the French court sale of Gauzy's Vision Systems division to Klains, as Klains does not hold the required aerospace operating permits, and the outcome of the upcoming September appeal could impact Gauzy's available capital.
  • If Research Frontiers pursues Plan D (acquiring Gauzy manufacturing assets), additional capital will need to be raised, which may require dilution of existing shareholders.

Q: If Gauzy cannot ramp up production quickly, why not immediately switch to a new manufacturer to end the revenue drag?

A: Gearing up a new automotive-qualified SPD film manufacturer takes time. Hitachi took 11 years from licensing to commercial automotive production, and while technology maturation means the timeline would be shorter today, this process can still take years. Research Frontiers is already pursuing this contingency in parallel with supporting Gauzy's restructuring.

Q: What is the current status of Gauzy production and shipments to customers?

A: Gauzy has continued shipping to customers using existing inventory during restructuring, prioritizing key ongoing programs to keep them moving. Following the recent court approval of Gauzy's Israeli debt restructuring plan, financing has started flowing to rehire workers and restart production at Gauzy's German facility.

Q: How does the company's NASDAQ delisting risk stand?

A: NASDAQ granted an 180-day compliance period that extends to the end of November 2026. Management is focused on regaining compliance through improved operational performance rather than a reverse stock split, and the SEC does not control listing standards — this is handled entirely by NASDAQ.

Q: What are the performance differences between Research Frontier's SPD technology and competitor Ambilight's electrochromic product used by BYD and Audi?

A: Like all electrochromic products, Ambilight's product slows down as it gets larger, which is a significant disadvantage for large sunroofs and automotive glass. SPD maintains fast switching regardless of size. Ambilight's penetration in China is partially driven by government direction rather than purely technical or commercial advantage, which does not exist for SPD in most global markets.

Q: When will revenue start increasing after production restarts, and will Gauzy be able to meet pent-up demand?

A: Management expects production to restart and volume to begin increasing before the end of 2026. Pent-up demand from delayed projects will be filled shortly after full production resumes, and all existing customer programs are ready to move forward immediately once film supply is restored.